Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL154P is a human cytoplasmic noncoding RNA pseudogene derived from the canonical 7SL RNA gene. The canonical 7SL RNA forms the structural RNA component of the signal recognition particle (SRP), which is essential for co-translational targeting and translocation of secretory and membrane proteins. Pseudogenes such as RN7SL154P are highly homologous but are generally nonfunctional copies and do not participate in SRP formation or canonical signal recognition processes. While some pseudogenes influence cellular processes by modulating RNA-binding proteins or acting as miRNA sponges, there is no specific evidence that RN7SL154P has such roles. Pseudogenes overall are not considered direct therapeutic targets, and drugs do not interact with these genetic elements. Key points: - RN7SL154P is a pseudogene, not an active gene product or therapeutic target. - Any biological functions ascribed to the family relate to canonical 7SL RNA, not to this pseudogene. - There is no evidence of involvement as a biomarker, disease driver, or drug target. For structured data extraction and downstream analysis, RN7SL154P should generally be classified as non-essential for target screening, drug development, or biomarker panels.
Not applicable for RN7SL154P. No drug mechanism targets RNA pseudogenes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 154, pseudogene (RN7SL154P).